13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Downregulation of WDR20 due to loss of 14q is involved in the malignant transformation of clear cell renal cell carcinoma

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Previously, we reported that genomic loss of 14q occurs more frequently in high‐grade than in low‐grade clear cell renal cell carcinomas (cc RCCs), and has a significant impact on the levels of expression of genes located in this region, suggesting that such genes may be involved in the malignant transformation of cc RCCs. Here, we found that six of the genes located in the minimal common region of 14q loss were significantly downregulated in high‐grade cc RCCs due to copy number loss. Using a dataset from The Cancer Genome Atlas Research Network, we found that downregulation of one of these six genes, WDR20 , was significantly associated with poorer outcome in patients with cc RCC, suggesting that WDR20 downregulation may be involved in the malignant transformation of cc RCCs. In functional assays, exogenous WDR20 significantly inhibited the growth of RCC cell lines and induced apoptosis. Interestingly, the phosphorylation levels of ERK and protein kinase B/AKT, which reportedly contribute to the malignant phenotype of RCC cells, were clearly reduced by exogenous expression of WDR20. Thus, our data suggest that downregulation of WDR20 due to 14q loss may be involved in the malignant transformation of cc RCCs, in part through activation of the ERK and protein kinase B/AKT pathways.

          Related collections

          Most cited references26

          • Record: found
          • Abstract: found
          • Article: not found

          Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.

          The cBioPortal for Cancer Genomics (http://cbioportal.org) provides a Web resource for exploring, visualizing, and analyzing multidimensional cancer genomics data. The portal reduces molecular profiling data from cancer tissues and cell lines into readily understandable genetic, epigenetic, gene expression, and proteomic events. The query interface combined with customized data storage enables researchers to interactively explore genetic alterations across samples, genes, and pathways and, when available in the underlying data, to link these to clinical outcomes. The portal provides graphical summaries of gene-level data from multiple platforms, network visualization and analysis, survival analysis, patient-centric queries, and software programmatic access. The intuitive Web interface of the portal makes complex cancer genomics profiles accessible to researchers and clinicians without requiring bioinformatics expertise, thus facilitating biological discoveries. Here, we provide a practical guide to the analysis and visualization features of the cBioPortal for Cancer Genomics.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Prognostic significance of morphologic parameters in renal cell carcinoma.

            The prognostic significance of morphologic parameters was evaluated in 103 patients with renal cell carcinoma diagnosed during 1961--1974. Pathologic material was classified as to pathologic stage, tumor size, cell arrangement, cell type and nuclear grade. Four nuclear grades (1--4) were defined in order of increasing nuclear size, irregularity and nucleolar prominence. Nuclear grade was more effective than each of the other parameters in predicting development of distant metastasis following nephrectomy. Among 45 patients who presented in Stage I, tumors classified as nuclear grade 1 did not metastasize for at least 5 years, whereas 50% of the higher grade tumors did so. Moreover, among Stage I tumors there was a significant difference in subsequent metastatic rate between nuclear grades 1 and 2. There was an apparent positive relationship between cell type and metastatic rate; clear cell tumors were less aggressive than predominantly granular cell tumors (metastatic rate 38% versus 71%). This relationship in part a function of the nuclear grade: only 5% of grade 3 and 4 tumors consisted of clear cells, whereas such high grades were seen in 57% of granular cell tumors. The size of the primary correlated well with the stage at the time of surgery. However, with the exception of extremely large and small tumors, the size was not useful in predicting the subsequent course of patients treated for Stage I tumors. Nuclear grade was the most significant prognostic criterion for the outcome of Stage I renal cell carcinoma.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The WD repeat: a common architecture for diverse functions.

              Our knowledge of the large family of proteins that contain the WD repeat continues to accumulate. The WD-repeat proteins are found in all eukaryotes and are implicated in a wide variety of crucial functions. The solution of the three-dimensional structure of one WD-repeat protein and the assumption that the structure will be common to all members of this family has allowed subfamilies of WD-repeat proteins to be defined on the basis of probable surface similarity. Proteins that have very similar surfaces are likely to have common binding partners and similar functions.
                Bookmark

                Author and article information

                Journal
                Cancer Sci
                Cancer Sci
                10.1111/(ISSN)1349-7006
                CAS
                Cancer Science
                John Wiley and Sons Inc. (Hoboken )
                1347-9032
                1349-7006
                04 March 2016
                April 2016
                : 107
                : 4 ( doiID: 10.1111/cas.2016.107.issue-4 )
                : 417-423
                Affiliations
                [ 1 ] Department of Molecular Pathology Faculty of MedicineOita University OitaJapan
                [ 2 ] Department of Urology Faculty of MedicineOita University OitaJapan
                [ 3 ] Research Promotion Institute Faculty of MedicineOita University OitaJapan
                [ 4 ] Department of Diagnostic Pathology Faculty of MedicineOita University OitaJapan
                [ 5 ] Department of Biology Faculty of MedicineOita University OitaJapan
                Author notes
                [*] [* ] Correspondence

                Keiko Matsuura, Department of Biology, Faculty of Medicine, Oita University Yufu‐city, Oita 879‐5593, Japan.

                Tel: +81‐97‐5865693; Fax: +81‐97‐5865699;

                E‐mail: matsuura@ 123456oita-u.ac.jp

                Article
                CAS12892
                10.1111/cas.12892
                4832870
                26790128
                14b59c7c-b071-4620-af8a-fc8b36632b86
                © 2016 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.

                This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 27 August 2015
                : 13 January 2016
                : 14 January 2016
                Page count
                Pages: 7
                Funding
                Funded by: Japanese Ministry of Education, Culture, Sports Science and Technology
                Award ID: 15K08405
                Categories
                Original Article
                Original Articles
                Carcinogenesis
                Custom metadata
                2.0
                cas12892
                April 2016
                Converter:WILEY_ML3GV2_TO_NLMPMC version:4.8.6 mode:remove_FC converted:15.04.2016

                Oncology & Radiotherapy
                14q loss,apoptosis,clear cell renal cell carcinoma,the cancer genome atlas,wdr20

                Comments

                Comment on this article